Home
 /
Papers
 /
Molecular Biology
 /
Extended nuclear glycosylation regulates RNA processing
Preprint
Open access
Top 1% · Validated by QED

Extended nuclear glycosylation regulates RNA processing

Jon Lundstrøm, Michelle Fong, Annika Thorsell +12 more
March 2026
 ·
bioRxiv
 ·
DOI 
10.64898/2025.12.02.691741
99
%
QED Score
QED Impressions

Overturning the dogma that extended glycosylation is confined to the secretory pathway, this paper shows nuclear proteins are glycosylated via Golgi-to-nucleus vesicular transport—linking glycans directly to tRNA processing and redefining glycobiology's cellular scope.

Run full QED analysis
Read paper
Save

Author perspective

What is the most important insight, discovery, or finding from your paper that you would like other scientists to know?
“

In this study, we were able to uncover a whole new layer of regulation by expanding the relevance of complex glycosylation to compartments beyond the secretory pathway. Our findings have resonated with many scientists who have seen glimpses of this phenomenon in their own experiments and data before, yet have usually discarded them as noise or artifacts. For us, it again strongly reinforces the idea that you often only see what you are looking for and that, sometimes, we need to look beyond known boundaries to advance biological research.

”
Daniel Bojar

QED claims analysis

Summary

Extended O-GalNAc glycans are biosynthesized in the Golgi apparatus and actively transported to mammalian nuclei via BIG1-dependent vesicular trafficking, where they modify RNA-binding proteins and regulate essential cellular processes including tRNA processing and protein synthesis, establishing glycosylation as a functionally significant post-translational modification beyond the secretory pathway.

See full analysis
Main Claim 1 –

Ultra-pure mammalian nuclei harbor extended protein glycosylation

Supporting evidence

  • Extended nuclear glycosylation occurs across diverse mammalian cell lines
  • Nuclear glycan signal is sialidase-sensitive and sialic acid-dependent
Main Claim 2 –

Nuclear sialylation requires secretory CMP-sialic acid transporter SLC35A1

Supporting evidence

  • Extended nuclear glycans can be imaged and enriched in living cells
Main Claim 3 –

Nuclei contain extended O-GalNAc glycans but lack complex N-glycans

Supporting evidence

  • Nuclear O-glycome is distinct from secretory pathway glycome
  • Sialylated nuclear glycoproteins can be enriched and identified proteomically
  • Sialidase exposes PNA epitopes on nuclear O-glycoproteins
  • Nuclear RNA-binding proteins co-purify with O-glycan-binding lectins
Main Claim 4 –

Nuclear O-glycan biosynthesis depends on canonical Golgi enzymes

Supporting evidence

  • SLC35A2-mediated galactose transport is required for nuclear glycosylation
  • Golgi manganese homeostasis modulates nuclear glycosylation levels

Abstract

In eukaryotes, glycans modify proteins in the secretory pathway and the extracellular space. Aside from nucleocytoplasmic O-GlcNAc, glycosylation is not considered a relevant post-translational modification in other cellular compartments. Here, we challenge this long-standing paradigm by showing that extended O-glycans are commonly found on intranuclear proteins. Through comprehensive genetic and biochemical analyses, we conclusively demonstrate that these O-glycans stem from the secretory pathway, yet are found on nuclear proteins across mammalian cell lines and primary cells. Using knock-out cell lines, we show mechanistically that nuclear glycans are shuttled to the nucleus via active vesicular transport. We identify several of these intranuclear glycoproteins as RNA-binding proteins, including KHSRP/FUBP2, RBM12, and RPP30. Lastly, we show that site-specific glycosylation of RPP30 is crucial for effective tRNA processing. Overall, our findings suggest a much broader role for glycosylation in regulating cellular functions and open up investigation into the role of glycans in more biological processes.

Related papers

How the QED Score works

QED Score is an AI-based quality metric for life science research. It rates each paper on two dimensions: originality (is the finding new and important?) and validity (does the evidence support the claims?). Author names and affiliations are removed before scoring. Each manuscript is broken down into its claims and the experiments behind them, and specialized AI agents then examine those claims for statistical rigor, consistency across figures, and contradictions with the existing literature. A verification layer re-checks every issue they flag. Scores are percentile ranks against all papers in the corpus. In a blinded study of papers where QED Score and journal rank disagreed, domain experts sided with QED Score in 75% of cases.
Read the methodology

Free access for academic researchers

Create your free QED account to validate your research, strengthen grant proposals, and uncover scientific insights.
We've sent you an access link.
Please check your inbox.

Didn't get your email? Check your spam folder or reach out to info@qedscience.com

Oops! Something went wrong while submitting the form.
Looking for QED for pharma, biotech or life science organizations?